Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: A Berlin-Frankfurt-Münster group report

Journal of Clinical Oncology

Volumn 25, Issue 25, 2007, Pages 3915-3922

  Salzburg, Janina ^b   Burkhardt, Birgit ^b   Zimmermann, Martin ^b   Wachowski, Olga ^b   Woessmann, Wilhelm ^b   Oschlies, Ilske ^b   Klapper, Wolfram ^b   Wacker, Hans Heinrich ^b   Ludwig, Wolf Dieter ^b   Niggli, Felix ^b   Mann, Georg ^b   Gadner, Helmut ^b   Riehm, Hansjoerg ^b   Schrappe, Martin ^b   Reiter, Alfred ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; AUSTRIA; CANCER DIAGNOSIS; CANCER STAGING; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; GERMANY; HUMAN; INFANT; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MENINX DISORDER; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SWITZERLAND; BRAIN TUMOR; CLASSIFICATION; FEMALE; HEAD AND NECK TUMOR; MALE; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; SPINAL CORD TUMOR; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPIDURAL NEOPLASMS; FEMALE; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOMA, NON-HODGKIN; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34548536531     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.0700     Document Type: Article

References (31)

1. Reiter A, Schrappe M, Ludwig WD, et al: Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report. Blood 95:416-421, 2000
2. Reiter A, Schrappe M, Tiemann M, et al: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899-908, 1994
3. Reiter A, Schrappe M, Tiemann M, et al: Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 94:3294-3306, 1999
4. Woessmann W, Seidemann K, Mann G, et al: The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: A report of the BFM Group Study NHL-BFM95. Blood 105:948-958, 2005
5. Burkhardt B, Zimmermann M, Oschlies I, et al: The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 131:39-49, 2005
6. Cairo MS, Sposto R, Perkins SL, et al: Burkitt's and Burkitt-like lymphoma in children and adolescents: A review of the Children's Cancer Group experience. Br J Haematol 120:660-670, 2003
7. Patte C, Auperin A, Michon J, et al: The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97:3370-3379, 2001
8. Williams DM, Hobson R, Imeson J, et al: Anaplastic large cell lymphoma in childhood: Analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol 117:812-820, 2002
9. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage-a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 13:359-372, 1995
10. Anderson JR, Wilson JF, Jenkin DT, et al: Childhood non-Hodgkin's lymphoma: The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med 308:559-565, 1983
11. Haddy TB, Adde MA, Magrath IT: CNS involvement in small noncleaved-cell lymphoma: Is CNS disease per se a poor prognostic sign? J Clin Oncol 9:1973-1982, 1991
12. Gururangan S, Sposto R, Cairo MS, et al: Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: A Children's Cancer Group study. J Clin Oncol 18:2017-2025, 2000
13. Sandlund JT, Murphy SB, Santana VM, et al: CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma. J Clin Oncol 18:3018-3024, 2000
14. Jaffe ES, Harris NL, Stein H, Vardiman J: WHO Classification, Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France, IARC Press, 2001
15. Murphy SB: Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: Dissimilarities from lymphomas in adults. Semin Oncol 7:332-339, 1980
16. Seidemann K, Tiemann M, Schrappe M, et al: Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 97:3699-3706, 2001
17. Reiter A, Schrappe M, Ludwig WD, et al: Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group. Blood 80:2471-2478, 1992
18. Burkhardt B, Woessmann W, Zimmermann M, et al: Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol 24:491-499, 2006
19. Kaplan EI, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
21. Kalbfleisch EL, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley, 1980, pp 163-188
22. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 2005:1141-1154, 1988
23. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
24. Cairo M, Gerrard M, Sposto R, et al: Deletion of cranial irradiation and addition of systemic high dose methotrexate and intrathecal chemotherapy results in 70% 4-yr EFS in children and adolescents with CNS positive B-NHL: Results of international FAB/LMB 96 study. Ann Oncol 62, 2005 (abstr 91)
25. Patte C, Leverger G, Perel Y, et al: Updated results of the LMB 86 protocol of the French Pediatric Society (SFOP) for B-cell non Hodgkin's lymphomas (B-NHL) with CNS involvement (CNS+) and B-ALL. Med Pediatr Oncol 397a, 1990 (abstr 18)
26. Shapiro WR, Young DF, Mehta BM: Methotrexate: Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293:161-166, 1975
27. Bleyer WA, Poplack DG, Simon RM: "Concentration x time" methotrexate via a subcutaneous reservoir: A less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 51:835-842, 1978
28. Eden OB, Hann I, Imeson J, et al: Treatment of advanced stage T cell lymphoblastic lymphoma: Results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol 82:310-316, 1992
29. Schulz H, Pels H, Schmidt-Wolf I, et al: Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab. Haematologica 89:753-754, 2004
30. Bomgaars L, Geyer JR, Franklin J, et al: Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol 22:3916-3921, 2004
31. Patte C, Bernard A, Hartmann O, et al: High-dose methotrexate and continuous infusion Ara-C in children's non-Hodgkin's lymphoma: Phase II studies and their use in further protocols. Pediatr Hematol Oncol 3:11-18, 1986